Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.
about
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansBalancing immunity and pathology in visceral leishmaniasis.Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytesThe immunology of parasite infections in immunocompromised hosts.Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis.Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.Leishmania infection inhibits cycloheximide-induced macrophage apoptosis in a strain-dependent manner.Tracing immunity to human leishmaniasis.Views of immunology: effector T cells.Role of host- and pathogen-associated lipids in directing the immune response in mycobacterial infections, with emphasis on Mycobacterium avium subsp. paratuberculosis.Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection.Leishmania donovani infection drives the priming of human monocyte-derived dendritic cells during Plasmodium falciparum co-infections.Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment.Effects of Leishmania major clones showing different levels of virulence on infectivity, differentiation and maturation of human dendritic cells.Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids.
P2860
Q28511526-47EC8417-726E-4BAE-B39F-C9534473CBB0Q34587432-2104966E-8CA2-453D-A144-7BE6585B65AEQ34983782-531E6746-E1B3-42B9-839A-63DB600A5640Q35029729-B0E038EC-690B-4659-85BC-74B38B5CAF43Q35217598-12E023A3-0D18-41CC-8D3D-875007CA5F39Q35845442-CE07C04B-3B3C-4DD5-BFCE-C383CACD2ACBQ36493625-E001F9A0-8834-4AF1-BA5C-FC15E842DA6FQ37118101-080D3032-2DF9-4C65-B42B-78DA860EEF6DQ37348828-341F984E-6729-4B70-9D2E-6840419C023FQ37405618-402E9680-93BB-469E-A4A3-8F9949DCF331Q37846863-47CE840E-0B3E-4653-8145-930EBDF0B559Q38243971-9D494CBF-2294-456D-B9DF-D9852C2A69EAQ39393627-A8D40F50-75ED-40FF-82FB-6DF4BAF593C2Q39548188-2B59139F-D851-4F84-8654-CE189FE9D109Q40935141-F5388C44-2389-4F95-9836-159F4FCD6F82Q43724325-C2E2D980-F35C-46B0-9134-46FE73C6C9E8Q46479941-EEA92682-B62C-49FC-9BE6-AF98E326DB3F
P2860
Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@ast
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@en
type
label
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@ast
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@en
prefLabel
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@ast
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@en
P2860
P1476
Inhibition of CD1 expression i ...... tion with Leishmania donovani.
@en
P2093
Gerald F Späth
Joseph L Amprey
P2860
P304
P356
10.1128/IAI.72.1.589-592.2004
P407
P577
2004-01-01T00:00:00Z